Skip to main content

Table 6 Vasoconstrictor drugs contraindicated or used with precautions for Raynaud’s phenomenon

From: French recommendations for the management of systemic sclerosis

Nasal decongestants by local or general administration
 Pseudoephedrine
 Phenylephrine
 Phenylpropanolamine
Migraine drugs derived from ergot
 Dihydroergotamine
 Ergotamine
Beta-blockers
Anti-glaucoma beta-blocker eye drops
Hyperprolactinemia treatments
 Bromocriptine
 Cabergoline
 Lisuride
Antiparkinsonians
 Pergolide